1. Relationship between cytotoxicity, drug accumulation, DNA damage and repair of human ovarian cancer cells treated with doxorubicin: modulation by the tiapamil analog RO11-2933

   • M. Abdellah Alaoui Jamali
   • Ming-biao Yin
   • Youcef M. Rustum

   Drug Accumulation, DNA Damage, Tiapamil Analog, RO11-2933, Doxorubicin, Cytotoxicity Pages: 77 - 83

2. Evaluation of N-(5-indanylsulfonyl)-N′-(4-chlorophenyl)-urea against xenografts of pediatric rhabdomyosarcoma

   • Peter J. Houghton
   • Janet A. Houghton
   • Gerald B. Grindey

   Xenografts, Sulfonyl Urea, Cytotoxicity Pages: 84 - 88

3. In vitro evaluation of cisplatin interaction with doxorubicin or 4-hydroperoxycyclophosphamide against human gynecologic cancer cell lines

   • Min-Jian Xu
   • David S. Alberts
   • Yun Liu

   Cisplatin, Cyclophosphamide, Doxorubicin, Gynecologic Cancer Cells Pages: 89 - 94

4. Effect of the irreversible aromatase inhibitor FCE 24304 on DMBA-induced mammary tumors in ovariectomized rats treated with testosterone

   • T. Zaccheo
   • E. Di Salle

   Aromatase Inhibitor, FCE 24304, DMBA-Induced Mammary Tumor, Rats Pages: 95 - 98

5. The influence of Fluosol-DA and carbogen breathing on the antitumor effects of cyclophosphamide in vivo

   • Gwi E. Kim
   • Chang W. Song

   Fluosol-DA, Carbogen Breathing, Antitumor Effects, Cyclophosphamide Pages: 99 - 102

6. Depletion of O⁶-alkylguanine-DNA alkyltransferase activity in mammalian tissues and human tumor xenografts in nude mice by treatment with O⁶-methylguanine

   • M. Eileen Dolan
   • Gregory L. Larkin
   • Anthony E. Pegg

   O6-Alkylguanine, O6-Methylguanine, Alkylating Agents, Xenografts Pages: 103 - 108

7. Nephrotoxicity of 5-(N-phenylcarboxamido)-2-thiobarbituric acid in the Fischer 344 rat

   • Yoshio Nakagawa
   • Robert A. Kramer

   Merbarone, Nephrotoxicity, Fischer 344 Rat Pages: 109 - 113

8. Morphological change and cellular differentiation induced by cisplatin in human neuroblastoma cell lines

   • Maria Teresa Parodi
   • Luigi Varesio
   • Gian Paolo Tonini

   Cisplatin, Morphological Change, Neuroblastoma Cells Pages: 114 - 116

9. Arabinofuranosyl-5-azacytosine: activity against human tumors in athymic mice

   • Roslyn E. Wallace
   • Dolores Lindh
   • F. E. Durr

   Ara-AC, Athymic Mice, Xenografts, Human Tumors Pages: 117 - 123

10. Effect of dipyridamole on fluorodeoxyuridine cytotoxicity in vitro and in cancer patients

    • Antonio C. Buzaid
    • David S. Alberts
    • Harinder S. Garewal

    Dipyridamole, Fluorodeoxyuridine, Cytotoxicity Pages: 124 - 130

11. Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer

    • D. J. TH. Wagener
    • Q. G. C. M. van Hoesel
    • S. P. Strijk

    5-Fluorouracil, Adriamycin, Cisplatin, Radiation, Pancreatic Cancer Pages: 131 - 134

12. Salvage chemotherapy of refractory non-Hodgkin's lymphoma with aclacinomycin, behenoyl ara-C, etoposide, and prednisolone

    • Takashi Yoshida
    • Shinobu Nakamura
    • Hideyo Natori

    Aclacinomycin Combination Therapy, Refractory Non-Hodgkin's Lymphoma Pages: 135 - 138

13. Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution

    • M. J. Lind
    • J. M. Margison
    • P. M. Wilkinson

    Ifosfamide, Drug Distribution. Pharmacokinetics, Bronchial Carcinoma Pages: 139 - 142

14. [¹³¹I]-Metaiodobenzylguanidine in the treatment of metastatic neuroblastoma

    • Thomas Klingebiel
    • Jörn Treuner
    • Dietrich Niethammer

    [131I]-Metaidobenzylguanidine, Neuroblastoma, Children Pages: 143 - 148